Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.43 |
| ▸ | LGALS3 | P17931 | 5/20 | 0.43 |
| ▸ | SLC5A2 | P31639 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | TACR2 | P21452 | 1/20 | 0.41 |
| ▸ | LGALS9 | O00182 | 2/20 | 0.41 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.41 |
| ▸ | LGALS2 | P05162 | 1/20 | 0.41 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.41 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.40 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.40 |
| ▸ | MTOR | P42345 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14490090 | 0.91 | SLC6A2 (0.54) | SLC6A2LGALS8PDE4DLGALS3SLC5A2 | |
| SCHEMBL13775032 | 0.90 | SLC6A2 (0.53) | SLC6A2LGALS8PDE4DLGALS3SLC5A2 | |
| SCHEMBL18385936 | 0.87 | SLC6A2 (0.50) | SLC6A2LGALS8PDE4DLGALS3SLC5A2 | |
| SCHEMBL12585283 | 0.87 | SLC6A2 (0.50) | SLC6A2LGALS8PDE4DLGALS3SLC5A2 | |
| SCHEMBL15280784 | 0.87 | SLC6A2 (0.50) | SLC6A2LGALS8PDE4DLGALS3SLC5A2 | |
| SCHEMBL15280760 | 0.87 | SLC6A2 (0.50) | SLC6A2LGALS8PDE4DLGALS3SLC5A2 | |
| SCHEMBL9392807 | 0.87 | SLC6A2 (0.45) | SLC6A2LGALS8PDE4DTSHRCYP2C19 | |
| SCHEMBL9800965 | 0.87 | SLC6A2 (0.60) | SLC6A2LGALS8PDE4DLGALS3SLC5A2 | |
| SCHEMBL9791503 | 0.87 | SLC6A2 (0.60) | SLC6A2LGALS8PDE4DLGALS3SLC5A2 | |
| SCHEMBL22034477 | 0.87 | SLC6A2 (0.60) | SLC6A2LGALS8PDE4DLGALS3SLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9243018-B2 | Synthetic heparin pentasaccharides | DR. REDDY'S LABORATORIES, SA (CH) | 2016-01-26 | — | — | US | disclosed |
| US-20150005485-A1 | SYNTHETIC HEPARIN PENTASACCHARIDES | ALCHEMIA LIMITED (AU) | 2015-01-01 | — | — | US | disclosed |
| US-8404833-B2 | Synthetic heparin disaccharides | ALCHEMIA LIMITED (AU) | 2013-03-26 | — | — | US | disclosed |
| US-20120220759-A1 | SYNTHETIC HEPARIN DISACCHARIDES | ALCHEMIA LIMITED (AU) | 2012-08-30 | — | — | US | disclosed |
| US-20120208993-A1 | SYNTHETIC HEPARIN TRISACCHARIDES | ALCHEMIA LIMITED (AU) | 2012-08-16 | — | — | US | disclosed |
| US-8114970-B2 | Synthetic heparin monosaccharides | ALCHEMIA LIMITED (AU) | 2012-02-14 | — | — | US | disclosed |
| US-20090187013-A1 | SYNTHETIC HEPARIN PENTASACCHARIDES | ALCHEMIA LIMITED (AU) | 2009-07-23 | — | — | US | disclosed |
| US-7541445-B2 | Synthetic heparin pentasaccharides | ALCHEMIA LIMITED (AU) | 2009-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090187013-A1 | SYNTHETIC HEPARIN PENTASACCHARIDES | HPSE, DDOST, STT3A | SLC6A2 4439/4885LGALS8 658/4885PDE4D 3414/4885 |
| US-20120220759-A1 | SYNTHETIC HEPARIN DISACCHARIDES | HPSE, DDOST, STT3A | SLC6A2 4126/4885LGALS8 609/4885PDE4D 3274/4885 |
| US-20150005485-A1 | SYNTHETIC HEPARIN PENTASACCHARIDES | HPSE, DDOST, STT3A | SLC6A2 4587/4885LGALS8 719/4885PDE4D 3671/4885 |
| US-20120208993-A1 | SYNTHETIC HEPARIN TRISACCHARIDES | HPSE, SERPINC1, DDOST | SLC6A2 4619/4885LGALS8 910/4885PDE4D 3786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.